» Articles » PMID: 15498903

Prostate Cancer: Evaluation of Vascular Characteristics with Dynamic Contrast-enhanced T1-weighted MR Imaging--initial Experience

Overview
Journal Radiology
Specialty Radiology
Date 2004 Oct 23
PMID 15498903
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To use contrast material-enhanced magnetic resonance (MR) imaging and a distributed-parameter tracer kinetics model for prospectively evaluating the vascular characteristics of prostate cancer.

Materials And Methods: Twenty-two patients between 57 and 76 years of age (mean age, 67 years) with histologically proved adenocarcinoma of the prostate were examined by using three-dimensional dynamic contrast-enhanced T1-weighted MR imaging at 1.5 T. The local research ethics committee approved this study, and written consent was obtained from all patients. Data from regions of interest drawn in tumor, normal-appearing peripheral zone tissue, and muscle were analyzed to provide estimates of perfusion, blood volume, interstitial volume, and microvascular permeability-surface area product. These estimates were compared by using the nonparametric Wilcoxon signed rank test.

Results: Mean blood flow was significantly (P < .001) higher in 22 prostate tumors than in 20 contralateral peripheral zones (66 vs 32 mL/100 mL/min). Similarly, the interstitial distribution volume in tumors was enlarged compared with the interstitial distribution volume in normal peripheral zones (42 vs 27 mL/100 mL). Blood volume and microvascular permeability-surface area product values in tumors (1.0 mL/100 mL and 22 mL/100 mL/min, respectively) were similar to estimated values in peripheral zone tissue (1.5 mL/100 mL and 21 mL/100 mL/min, respectively).

Conclusion: These findings show considerable promise for isolating vascular characteristics of prostate cancer.

Citing Articles

Slice profile effects on quantitative analysis of hyperpolarized pyruvate.

Walker C, Gordon J, Xu Z, Michel K, Li L, Larson P NMR Biomed. 2020; 33(10):e4373.

PMID: 32743881 PMC: 7484340. DOI: 10.1002/nbm.4373.


A compact solution for estimation of physiological parameters from ultrafast prostate dynamic contrast enhanced MRI.

He D, Fan X, Chatterjee A, Wang S, Medved M, Pineda F Phys Med Biol. 2019; 64(15):155012.

PMID: 31220816 PMC: 7227457. DOI: 10.1088/1361-6560/ab2b62.


Temperature-controlled power modulation compensates for heterogeneous nanoparticle distributions: a computational optimization analysis for magnetic hyperthermia.

Kandala S, Liapi E, Whitcomb L, Attaluri A, Ivkov R Int J Hyperthermia. 2018; 36(1):115-129.

PMID: 30541354 PMC: 6411438. DOI: 10.1080/02656736.2018.1538538.


MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence.

Glaser Z, Porter K, Thomas J, Gordetsky J, Rais-Bahrami S Transl Androl Urol. 2018; 7(Suppl 4):S411-S419.

PMID: 30363494 PMC: 6178314. DOI: 10.21037/tau.2018.03.21.


A systematic review on multiparametric MR imaging in prostate cancer detection.

Fusco R, Sansone M, Granata V, Setola S, Petrillo A Infect Agent Cancer. 2017; 12:57.

PMID: 29093748 PMC: 5663098. DOI: 10.1186/s13027-017-0168-z.